{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:29:51Z","timestamp":1793683791225,"version":"4.5.1"},"reference-count":33,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T00:00:00Z","timestamp":1124755200000},"content-version":"vor","delay-in-days":2610,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Cancer Research"],"published-print":{"date-parts":[[1998,7]]},"abstract":"<jats:p>Treatment with IDEC\u2010C2B8 (C2B8), the chimeric anti\u2010CD20 antibody, was shown in a phase I\u2010II study to be very effective for the treatment of low\u2010grade B\u2010cell lymphoma, in contrast to the results of most previous immunotherapies with monoclonal antibodies. In a study designed to elucidate the reason for this efficacy, two cell lines derived from lymphomas with BCL2 gene rearrangement (SU\u2010DHL\u20104 and SU\u2010DHL\u20106) showed remarkable growth inhibition and cell\u2010death, and two other cell lines derived from a diffuse lymphoma (RC\u2010K8) and a mantle cell lymphoma (SP\u201049) showed moderate growth inhibition, but neither a CD20 weakly positive cell line (NALL\u20101) nor a negative cell line (MOLT\u20104) showed any growth inhibition. An examination of the intensity of cell\u2010surface CD20 expression showed no correlation between intensity and degree of growth inhibition among the four cell lines showing growth inhibition. Morphological examination revealed condensed and fragmented nuclei and budding of the plasma membrane, both characteristic of apoptosis, with some cells in these cell lines showing growth inhibition by C2B8. Such apoptosis was also confirmed by flow cytometric analysis, suggesting that, at least in part, apoptosis plays a role in this growth inhibition. This growth\u2010inhibitory mechanism may thus account for the effectiveness of C2B8 antibody therapy.<\/jats:p>","DOI":"10.1111\/j.1349-7006.1998.tb03280.x","type":"journal-article","created":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T14:37:39Z","timestamp":1124807859000},"page":"748-756","source":"Crossref","is-referenced-by-count":62,"title":["Growth Inhibition of CD20\u2010positive B Lymphoma Cell Lines by IDEC\u2010C2B8 Anti\u2010CD20 Monoclonal Antibody"],"prefix":"10.1111","volume":"89","author":[{"given":"Hirohumi","family":"Taji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitoyo","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Andou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2047874"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.4.863.863"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.6.1349.bloodjournal6561349"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210223271705"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.9.3129"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90588-0"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.6.1431.1431"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.435.435"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.8.2457.2457"},{"issue":"54","key":"e_1_2_1_11_2","article-title":"IDEC\u2010C2B8 anti\u2010CD20 antibody: results of long\u2010term follow\u2010up of relapsed NHL Phase II trial patients","volume":"86","author":"Maloney D. G.","year":"1995","journal-title":"Blood"},{"issue":"55","key":"e_1_2_1_12_2","article-title":"IDEC\u2010C2B8 and CHOP chemoimmunotherapy of low\u2010grade lymphoma","volume":"86","author":"Czuczman M. S.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90276-3"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4049\/jimmunol.133.2.1028","article-title":"Two new monoclonal antibodies (LN\u20101, LN\u20102) reactive in B5 formalin\u2010fixed, paraffin\u2010embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors","volume":"133","author":"Epstein A. L.","year":"1987","journal-title":"J. Immunol."},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V67.2.391.391","article-title":"Immunoglobulin genes rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation","volume":"67","author":"Siminovitch K. A.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(85)80070-2"},{"key":"e_1_2_1_17_2","first-page":"1182","article-title":"Establishment of a new human B cell line carrying t(11;14) chromosome abnormality","volume":"78","author":"Daibata M.","year":"1987","journal-title":"Jpn. J. Cancer Res."},{"key":"e_1_2_1_18_2","first-page":"6708","article-title":"Rearrangements on chromosome 11q23 in hematopoietic tumor\u2010associated t(11;14) and t(11;19) translocations","volume":"51","author":"Akao Y.","year":"1991","journal-title":"Cancer Res."},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(73)91346-6"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19960615)26:2<137::AID-CYTO7>3.0.CO;2-D"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19961215)26:4<265::AID-CYTO5>3.0.CO;2-B"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1415.bloodjournal8451415"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood.V85.2.532.532","article-title":"Human neutrophils lose their surface Fc \u03b3 RIII and acquire annexin V binding sites during apoptosis in vitro","volume":"85","author":"Homburg C. H. E.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711050103"},{"key":"e_1_2_1_27_2","first-page":"418","article-title":"Pharmacokinetic analysis of serum concentrations of the chimeric anti\u2010CD20 antibody IDEC\u2010C2B8 in patients with relapsed B cell lymphoma","volume":"15","author":"Rosenberg J.","year":"1996","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.135.2.973","article-title":"The B cell surface molecule B1 is functionally linked with B cell activation and differentiation","volume":"135","author":"Tedder T. F.","year":"1985","journal-title":"J. Immunol."},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830160802"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.4049\/jimmunol.135.6.3795","article-title":"The CD20 (Bp35) antigen involved in activation of B cells from the GO to the G1 phase of the cell cycle","volume":"135","author":"Golay J. T.","year":"1985","journal-title":"J. Immunol."},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.5.1747"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830251126"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830221217"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.5.1644"}],"container-title":["Japanese Journal of Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.1998.tb03280.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.1998.tb03280.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T22:35:25Z","timestamp":1698532525000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.1998.tb03280.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1111\/j.1349-7006.1998.tb03280.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.1998.tb03280.x","archive":["Portico"],"relation":{},"ISSN":["0910-5050"],"issn-type":[{"value":"0910-5050","type":"print"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}